Cargando…
White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer’s disease
BACKGROUND: Acetylcholinesterase inhibitor (AChEI) drug regimens are the mainstay treatment options for patients with Alzheimer’s disease (AD). Herein, We examined the association between clinical response to AChEI and white matter hyperintensities on magnetic resonance imaging (MRI) scan at baselin...
Autores principales: | Lee, Li-Hua, Wu, Shu-Ching, Ho, Cheng-Feng, Liang, Wan-Lin, Liu, Yi-Chien, Chou, Chia-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065432/ https://www.ncbi.nlm.nih.gov/pubmed/37000849 http://dx.doi.org/10.1371/journal.pone.0283790 |
Ejemplares similares
-
White matter hyperintensities in cholinergic pathways are associated with dementia severity in e4 carriers but not in non-carriers
por: Yu, Ming-Chun, et al.
Publicado: (2023) -
White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages
por: Chen, Tai-Yi, et al.
Publicado: (2022) -
Independent and additive contribution of white matter hyperintensities and Alzheimer’s disease pathology to basal forebrain cholinergic system degeneration
por: Kindler, Christine, et al.
Publicado: (2023) -
Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?
por: Brickman, Adam M., et al.
Publicado: (2009) -
The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)